Balance Sheet Divi's Laboratories Limited

Stocks

DIVISLAB

INE361B01024

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:08 21/07/2026 pm IST			5-day change	1st Jan Change
7,330.00 ^INR	+0.16%		+1.97%	+14.67%

26/05	Divi's Laboratories Limited announces Annual dividend, payable on September 09, 2026	CI
25/05	Choice Equity Upgrades Divi's Laboratories to Add from Reduce; Price Target is INR7,375	MT

0a36f7305fa6384988f1d5.1YETN8WZOJXB08ccoPhl2jYgJfDZg5kn8zMjIJxCaIM.isx_A_TtZ9OxjKJx9Z4yllViHb2Oy9dDy0RQSMYoB9qi91VZgdtI1o6mhg

Published financial data: DIVI'S LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	8.96TCr	7.77TCr	7.84TCr	9.36TCr	11TCr
Other Revenues, Total	9L	10L	-	-	-
Total Revenues	8.96TCr	7.77TCr	7.84TCr	9.36TCr	11TCr
Cost of Goods Sold, Total	3.17TCr	3.28TCr	3.35TCr	3.94TCr	4.32TCr
Gross Profit	5.79TCr	4.49TCr	4.49TCr	5.42TCr	6.24TCr
Selling General & Admin Expenses, Total	957.09Cr	987.04Cr	1.11TCr	1.26TCr	1.46TCr
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	311.51Cr	343.18Cr	378Cr	402Cr	463Cr
Other Operating Expenses	952.58Cr	1.13TCr	1.18TCr	1.2TCr	1.34TCr
Other Operating Expenses, Total	2.22TCr	2.46TCr	2.66TCr	2.86TCr	3.26TCr
Operating Income	3.57TCr	2.03TCr	1.83TCr	2.57TCr	2.98TCr
Interest Expense, Total	-37L	-33L	-3Cr	-2Cr	-23Cr
Interest And Investment Income	69Cr	204.59Cr	301Cr	295Cr	284Cr
Net Interest Expenses	69Cr	204.26Cr	298Cr	293Cr	261Cr
Currency Exchange Gains (Loss)	41Cr	129.67Cr	30Cr	48Cr	211Cr
Other Non Operating Income (Expenses)	3.81Cr	9.96Cr	3Cr	4Cr	8Cr
EBT, Excl. Unusual Items	3.69TCr	2.37TCr	2.16TCr	2.92TCr	3.46TCr
Gain (Loss) On Sale Of Investments	-	-	5Cr	5Cr	4Cr
Gain (Loss) On Sale Of Assets	-2.05Cr	-1.13Cr	-4Cr	-4Cr	-
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-74Cr
EBT, Incl. Unusual Items	3.68TCr	2.37TCr	2.16TCr	2.92TCr	3.39TCr
Income Tax Expense	723.05Cr	545.25Cr	563Cr	725Cr	820Cr
Earnings From Continuing Operations	2.96TCr	1.82TCr	1.6TCr	2.19TCr	2.57TCr
Net Income to Company	2.96TCr	1.82TCr	1.6TCr	2.19TCr	2.57TCr
Net Income - (IS)	2.96TCr	1.82TCr	1.6TCr	2.19TCr	2.57TCr
Net Income to Common Incl Extra Items	2.96TCr	1.82TCr	1.6TCr	2.19TCr	2.57TCr
Net Income to Common Excl. Extra Items	2.96TCr	1.82TCr	1.6TCr	2.19TCr	2.57TCr
Per Share Items
Net EPS - Basic	111.52	68.69	60.27	82.53	96.73
Basic EPS - Continuing Operations	111.52	68.69	60.27	82.53	96.73
Basic Weighted Average Shares Outstanding	27Cr	27Cr	27Cr	27Cr	27Cr
Net EPS - Diluted	111.52	68.69	60.27	82.53	96.73
Diluted EPS - Continuing Operations	111.52	68.69	60.27	82.53	96.73
Diluted Weighted Average Shares Outstanding	27Cr	27Cr	27Cr	27Cr	27Cr
Normalized Basic EPS	86.77	55.79	50.9	68.63	81.41
Normalized Diluted EPS	86.77	55.79	50.9	68.63	81.41
Dividend Per Share	30	30	30	30	30
Payout Ratio	17.93	43.68	49.75	36.33	31.04
Supplemental Items
EBITDA	3.88TCr	2.36TCr	2.2TCr	2.97TCr	3.44TCr
EBITA	3.57TCr	2.03TCr	1.83TCr	2.57TCr	2.98TCr
EBIT	3.57TCr	2.03TCr	1.83TCr	2.57TCr	2.98TCr
EBITDAR	3.89TCr	2.38TCr	2.22TCr	2.98TCr	3.46TCr
Total Revenues (As Reported)	9.07TCr	8.11TCr	8.18TCr	9.71TCr	11TCr
Effective Tax Rate - (Ratio)	19.63	23.02	26.03	24.86	24.2
Total Current Taxes	644Cr	439.17Cr	514Cr	799Cr	868Cr
Total Deferred Taxes	79Cr	106.08Cr	49Cr	-74Cr	-48Cr
Normalized Net Income	2.3TCr	1.48TCr	1.35TCr	1.82TCr	2.16TCr
Interest on Long-Term Debt	15L	15L	-	-	-
Non-Cash Pension Expense	-18L	11L	0	0	74Cr
Supplemental Operating Expense Items
Advertising Expense	16L	15L	-	-	-
Selling and Marketing Expenses	16L	15L	-	-	-
Research And Development Expense From Footnotes	55Cr	69Cr	79Cr	80Cr	101Cr
Net Rental Expense, Total	11Cr	12Cr	12Cr	15Cr	18Cr
Imputed Operating Lease Interest Expense	7.48Cr	9.02Cr	82Cr	69Cr	602.18Cr
Imputed Operating Lease Depreciation	3.29Cr	2.85Cr	-70Cr	-54Cr	-584.18Cr
Maintenance & Repair Expenses, Total	199.03Cr	223.48Cr	223Cr	210Cr	230Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	1.21TCr	169.7Cr	363Cr	415Cr	128Cr
Short Term Investments	1.53TCr	3.96TCr	3.34TCr	3.11TCr	3.1TCr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	2.74TCr	4.13TCr	3.7TCr	3.53TCr	3.23TCr
Accounts Receivable, Total	2.42TCr	1.79TCr	2.16TCr	2.73TCr	3.11TCr
Other Receivables	104.46Cr	141.14Cr	205Cr	247Cr	342Cr
Notes Receivable	-	-	-	-	-
Total Receivables	2.53TCr	1.93TCr	2.36TCr	2.98TCr	3.45TCr
Inventory	2.83TCr	3TCr	3.18TCr	3.24TCr	3.95TCr
Prepaid Expenses	27Cr	27Cr	36Cr	37Cr	26Cr
Other Current Assets, Total	225.79Cr	218.1Cr	396Cr	303Cr	432Cr
Total Current Assets	8.35TCr	9.31TCr	9.68TCr	10TCr	11TCr
Gross Property Plant And Equipment	6.07TCr	6.55TCr	7.51TCr	8.86TCr	11TCr
Accumulated Depreciation	-1.28TCr	-1.62TCr	-1.99TCr	-2.4TCr	-2.86TCr
Net Property Plant And Equipment	4.79TCr	4.93TCr	5.51TCr	6.46TCr	8.64TCr
Long-term Investments	72Cr	77Cr	82Cr	65Cr	69Cr
Other Intangibles, Total	7.49Cr	5.28Cr	4Cr	4Cr	6Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	14Cr	14Cr	10Cr	11Cr	14Cr
Other Long-Term Assets, Total	141.75Cr	101.26Cr	186Cr	311Cr	213Cr
Total Assets	13TCr	14TCr	15TCr	17TCr	20TCr
Liabilities
Accounts Payable, Total	795.7Cr	762.51Cr	824Cr	910Cr	1.21TCr
Accrued Expenses, Total	323.46Cr	255.77Cr	244Cr	346Cr	403Cr
Short-term Borrowings	-	-	-	2Cr	-
Current Portion of Leases	82L	49L	1Cr	-	2Cr
Current Income Taxes Payable	1.68Cr	2.21Cr	43Cr	-	12Cr
Unearned Revenue Current, Total	76L	87L	1Cr	1Cr	269Cr
Other Current Liabilities	73Cr	79Cr	165Cr	193Cr	146Cr
Total Current Liabilities	1.2TCr	1.1TCr	1.28TCr	1.45TCr	2.04TCr
Long-Term Leases	2.87Cr	2.77Cr	2Cr	2Cr	5Cr
Pension & Other Post Retirement Benefits	-	-	-	-	81Cr
Deferred Tax Liability Non Current	421.4Cr	537.21Cr	582Cr	509Cr	469Cr
Other Non Current Liabilities	27Cr	31Cr	37Cr	-	674Cr
Total Liabilities	1.65TCr	1.67TCr	1.9TCr	1.96TCr	3.27TCr
Common Stock, Total	53Cr	53Cr	53Cr	53Cr	53Cr
Additional Paid In Capital	80Cr	80Cr	80Cr	80Cr	80Cr
Retained Earnings	12TCr	13TCr	13TCr	15TCr	17TCr
Comprehensive Income and Other	16Cr	25Cr	26Cr	31Cr	46Cr
Total Common Equity	12TCr	13TCr	14TCr	15TCr	17TCr
Total Equity	12TCr	13TCr	14TCr	15TCr	17TCr
Total Liabilities And Equity	13TCr	14TCr	15TCr	17TCr	20TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	27Cr	27Cr	27Cr	27Cr	27Cr
ECS Total Common Shares Outstanding	27Cr	27Cr	27Cr	27Cr	27Cr
Book Value / Share	441.79	480.93	511.21	563.87	631.37
Tangible Book Value	12TCr	13TCr	14TCr	15TCr	17TCr
Tangible Book Value Per Share	441.51	480.73	511.06	563.72	631.15
Total Debt	3.69Cr	3.26Cr	3Cr	4Cr	7Cr
Net Debt	-2.74TCr	-4.13TCr	-3.7TCr	-3.52TCr	-3.23TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-2.37Cr	-78L	-10Cr	1Cr	81Cr
Debt Equivalent Oper. Leases	86Cr	95Cr	96Cr	120Cr	144Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	782.18Cr	981.05Cr	1.1TCr	1.05TCr	1.45TCr
Inventories - Work In Process, Total	1.53TCr	1.53TCr	1.62TCr	1.7TCr	1.97TCr
Inventories - Finished Goods, Total	319.15Cr	302Cr	317Cr	335Cr	349Cr
Inventories - Others	195.7Cr	191.65Cr	148Cr	157Cr	185Cr
Land - (BS)	172.74Cr	194.23Cr	195Cr	202Cr	306Cr
Machinery, Total	3.99TCr	4.58TCr	4.86TCr	5.5TCr	6.63TCr
Full Time Employees	16.54T	8.43T	9.74T	10.54T	11.56T
Accumulated Allowance for Doubtful Accounts (Supple)	5.12Cr	5.87Cr	10Cr	7Cr	9Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	2.96TCr	1.82TCr	1.6TCr	2.19TCr	2.57TCr
Depreciation & Amortization - CF	308.33Cr	339.26Cr	375Cr	399Cr	461Cr
Depreciation & Amortization, Total	308.33Cr	339.26Cr	375Cr	399Cr	461Cr
Amortization of Deferred Charges, Total - (CF)	3.18Cr	3.92Cr	3Cr	3Cr	2Cr
(Gain) Loss From Sale Of Asset	2.05Cr	1.13Cr	4Cr	4Cr	-
(Gain) Loss on Sale of Investments - (CF)	-	-5.04Cr	-5Cr	-4Cr	-4Cr
Asset Writedown & Restructuring Costs	-	-	-	-	-
Provision and Write-off of Bad Debts	-2.03Cr	33L	4Cr	-2Cr	1Cr
Other Operating Activities, Total	10Cr	-122.06Cr	-113Cr	-384Cr	-389Cr
Change In Accounts Receivable	-741.62Cr	650.41Cr	-361Cr	-582Cr	-141Cr
Change In Inventories	-683.39Cr	-171.79Cr	-184Cr	-52Cr	-718Cr
Change In Accounts Payable	34Cr	-34Cr	62Cr	95Cr	294Cr
Change in Other Net Operating Assets	20Cr	-26Cr	-124Cr	-15Cr	664Cr
Cash from Operations	1.91TCr	2.46TCr	1.26TCr	1.65TCr	2.74TCr
Capital Expenditure	-713.2Cr	-473.02Cr	-1TCr	-1.44TCr	-2.52TCr
Sale of Property, Plant, and Equipment	-	1L	-	-	3Cr
Investment in Marketable and Equity Securities, Total	-1.55TCr	-2.44TCr	434Cr	339Cr	14Cr
Other Investing Activities, Total	67Cr	204.59Cr	300Cr	295Cr	284Cr
Cash from Investing	-2.19TCr	-2.71TCr	-269Cr	-804Cr	-2.22TCr
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-35L	-	-	-	-
Long-Term Debt Repaid, Total	-79L	-43L	-1Cr	-1Cr	-2Cr
Total Debt Repaid	-1.14Cr	-43L	-1Cr	-1Cr	-2Cr
Common Dividends Paid	-530.94Cr	-796.41Cr	-796Cr	-796Cr	-797Cr
Common & Preferred Stock Dividends Paid	-530.94Cr	-796.41Cr	-796Cr	-796Cr	-797Cr
Other Financing Activities, Total	-36L	-33L	-2Cr	-2Cr	-5Cr
Cash from Financing	-532.44Cr	-797.17Cr	-799Cr	-799Cr	-804Cr
Net Change in Cash	-815.56Cr	-1.05TCr	193Cr	50Cr	-285Cr
Supplemental Items
Cash Interest Paid	37L	66L	3Cr	2Cr	5Cr
Cash Income Tax Paid (Refund)	640.98Cr	472.65Cr	376Cr	824Cr	862Cr
Levered Free Cash Flow	398.4Cr	1.47TCr	-103.5Cr	165Cr	-928.12Cr
Unlevered Free Cash Flow	398.63Cr	1.47TCr	-101.62Cr	166.25Cr	-913.75Cr
Change In Net Working Capital	1.43TCr	-336.32Cr	621Cr	404Cr	718Cr
Net Debt Issued / Repaid	-1.14Cr	-43L	-1Cr	-1Cr	-2Cr

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	18.49	9.1	7.65	9.91	10.07
Return on Total Capital	21.23	10.34	8.69	11.25	11.73
Return On Equity %	28.16	14.89	12.15	15.35	16.19
Return on Common Equity	28.16	14.89	12.15	15.35	16.19
Margin Analysis
Gross Profit Margin %	64.66	57.81	57.27	57.96	59.06
SG&A Margin	10.68	12.71	14.1	13.44	13.83
EBITDA Margin %	43.3	30.44	28.11	31.71	32.56
EBITA Margin %	39.87	26.08	23.34	27.46	28.2
EBIT Margin %	39.87	26.08	23.34	27.46	28.2
Income From Continuing Operations Margin %	33.04	23.47	20.4	23.41	24.32
Net Income Margin %	33.04	23.47	20.4	23.41	24.32
Net Avail. For Common Margin %	33.04	23.47	20.4	23.41	24.32
Normalized Net Income Margin	25.71	19.07	17.22	19.46	20.47
Levered Free Cash Flow Margin	4.45	18.96	-1.32	1.76	-8.79
Unlevered Free Cash Flow Margin	4.45	18.96	-1.3	1.78	-8.65
Asset Turnover
Asset Turnover	0.74	0.56	0.52	0.58	0.57
Fixed Assets Turnover	1.95	1.6	1.5	1.56	1.4
Receivables Turnover (Average Receivables)	4.37	3.68	3.97	3.83	3.62
Inventory Turnover (Average Inventory)	1.27	1.12	1.08	1.23	1.2
Short Term Liquidity
Current Ratio	6.99	8.46	7.57	6.94	5.43
Quick Ratio	4.41	5.51	4.74	4.48	3.27
Operating Cash Flow to Current Liabilities	1.6	2.23	0.99	1.14	1.34
Days Sales Outstanding (Average Receivables)	83.52	99.07	92.12	95.29	100.93
Days Outstanding Inventory (Average Inventory)	286.7	324.61	337.61	297.75	303.53
Average Days Payable Outstanding	73.9	82.45	82.08	79.37	76.79
Cash Conversion Cycle (Average Days)	296.31	341.22	347.65	313.67	327.67
Long Term Solvency
Total Debt/Equity	0.03	0.03	0.02	0.03	0.04
Total Debt / Total Capital	0.03	0.03	0.02	0.03	0.04
LT Debt/Equity	0.02	0.02	0.01	0.01	0.03
Long-Term Debt / Total Capital	0.02	0.02	0.01	0.01	0.03
Total Liabilities / Total Assets	12.31	11.58	12.28	11.59	16.33
EBIT / Interest Expense	9.66T	6.14T	610.33	1.28T	129.48
EBITDA / Interest Expense	10.49T	7.17T	735.33	1.48T	149.52
(EBITDA - Capex) / Interest Expense	8.56T	5.73T	401	765.5	39.96
Total Debt / EBITDA	0	0	0	0	0
Net Debt / EBITDA	-0.71	-1.75	-1.67	-1.19	-0.94
Total Debt / (EBITDA - Capex)	0	0	0	0	0.01
Net Debt / (EBITDA - Capex)	-0.86	-2.18	-3.07	-2.3	-3.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	28.56	-13.31	1	19.31	12.82
Gross Profit, 1 Yr. Growth %	28.97	-22.5	0	20.93	14.97
EBITDA, 1 Yr. Growth %	35.36	-39.07	-6.73	34.6	15.84
EBITA, 1 Yr. Growth %	36.63	-43.29	-9.62	40.36	15.88
EBIT, 1 Yr. Growth %	36.63	-43.29	-9.62	40.36	15.88
Earnings From Cont. Operations, 1 Yr. Growth %	49.19	-38.41	-12.28	36.94	17.21
Net Income, 1 Yr. Growth %	49.19	-38.41	-12.28	36.94	17.21
Normalized Net Income, 1 Yr. Growth %	38.07	-35.7	-8.58	34.83	18.63
Diluted EPS Before Extra, 1 Yr. Growth %	49.19	-38.41	-12.26	36.93	17.21
Accounts Receivable, 1 Yr. Growth %	44.58	-26.05	20.25	26.67	13.84
Inventory, 1 Yr. Growth %	31.86	6.07	6.13	1.63	22.19
Net Property, Plant and Equip., 1 Yr. Growth %	8.57	2.96	11.85	17.18	33.67
Total Assets, 1 Yr. Growth %	24.14	7.96	7.14	9.45	18.31
Tangible Book Value, 1 Yr. Growth %	26.17	8.88	6.31	10.3	11.96
Common Equity, 1 Yr. Growth %	26.18	8.86	6.3	10.3	11.97
Cash From Operations, 1 Yr. Growth %	-1.8	28.66	-48.72	31.09	65.64
Capital Expenditures, 1 Yr. Growth %	-21.64	-33.68	112.05	43.37	75.24
Levered Free Cash Flow, 1 Yr. Growth %	-47.49	269.59	-107.03	-259.42	-662.5
Unlevered Free Cash Flow, 1 Yr. Growth %	-47.47	269.43	-106.9	-263.59	-649.62
Dividend Per Share, 1 Yr. Growth %	50	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.88	5.57	-6.43	9.78	16.02
Gross Profit, 2 Yr. CAGR %	35.74	-0.02	-11.94	9.88	17.91
EBITDA, 2 Yr. CAGR %	45.91	-9.18	-24.62	12.05	24.87
EBITA, 2 Yr. CAGR %	47.63	-11.98	-28.41	12.63	27.53
EBIT, 2 Yr. CAGR %	47.63	-11.98	-28.41	12.63	27.53
Earnings From Cont. Operations, 2 Yr. CAGR %	46.65	-4.14	-26.48	9.6	26.69
Net Income, 2 Yr. CAGR %	46.65	-4.14	-26.48	9.6	26.69
Normalized Net Income, 2 Yr. CAGR %	44.57	-5.78	-23.41	11.02	26.47
Diluted EPS Before Extra, 2 Yr. CAGR %	46.66	-4.14	-26.48	9.61	26.69
Accounts Receivable, 2 Yr. CAGR %	30.96	3.4	-5.69	23.42	20.08
Inventory, 2 Yr. CAGR %	23.19	18.26	6.1	3.86	11.44
Net Property, Plant and Equip., 2 Yr. CAGR %	13.78	5.73	7.31	14.48	25.15
Total Assets, 2 Yr. CAGR %	25.18	15.76	7.55	8.29	13.8
Tangible Book Value, 2 Yr. CAGR %	26.66	17.21	7.59	8.29	11.13
Common Equity, 2 Yr. CAGR %	26.67	17.2	7.57	8.28	11.13
Cash From Operations, 2 Yr. CAGR %	25.39	12.4	-18.78	-18.01	47.35
Capital Expenditures, 2 Yr. CAGR %	-22.36	-27.91	18.59	74.36	58.51
Levered Free Cash Flow, 2 Yr. CAGR %	28.78	39.31	-49.03	-66.52	199.46
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.76	39.3	-49.51	-66.4	199.86
Dividend Per Share, 2 Yr. CAGR %	36.93	22.47	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.9	12.92	4.02	1.47	10.78
Gross Profit, 3 Yr. CAGR %	24.23	12.61	0	-2.17	11.55
EBITDA, 3 Yr. CAGR %	27.44	9.06	-8.37	-8.54	13.3
EBITA, 3 Yr. CAGR %	27.87	7.31	-11.2	-10.4	13.7
EBIT, 3 Yr. CAGR %	27.87	7.31	-11.2	-10.4	13.7
Earnings From Cont. Operations, 3 Yr. CAGR %	29.83	9.82	-6.92	-9.55	12.08
Net Income, 3 Yr. CAGR %	29.83	9.82	-6.92	-9.55	12.08
Normalized Net Income, 3 Yr. CAGR %	26.3	10.35	-6.79	-7.52	13.5
Diluted EPS Before Extra, 3 Yr. CAGR %	29.83	9.83	-6.92	-9.55	12.09
Accounts Receivable, 3 Yr. CAGR %	27.72	8.24	8.75	4.06	20.14
Inventory, 3 Yr. CAGR %	16.86	17.2	14.07	4.59	9.64
Net Property, Plant and Equip., 3 Yr. CAGR %	22.95	10.05	7.73	10.5	20.55
Total Assets, 3 Yr. CAGR %	18.5	19.15	12.82	8.18	11.53
Tangible Book Value, 3 Yr. CAGR %	19.01	20.43	13.46	8.49	9.5
Common Equity, 3 Yr. CAGR %	19.01	20.43	13.45	8.47	9.5
Cash From Operations, 3 Yr. CAGR %	26.06	26.47	-13.48	-4.73	3.65
Capital Expenditures, 3 Yr. CAGR %	-0.91	-26.33	3.29	26.33	74.65
Levered Free Cash Flow, 3 Yr. CAGR %	124.48	83.01	-48.52	-25.46	-14.26
Unlevered Free Cash Flow, 3 Yr. CAGR %	121.78	83.91	-48.84	-25.29	-14.7
Dividend Per Share, 3 Yr. CAGR %	23.31	23.31	14.47	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.13	14.82	9.66	11.65	8.67
Gross Profit, 5 Yr. CAGR %	18.75	14.62	8.25	11.52	6.78
EBITDA, 5 Yr. CAGR %	21.14	13.27	3.3	10.25	3.7
EBITA, 5 Yr. CAGR %	21.2	12.43	1.39	9.41	2.64
EBIT, 5 Yr. CAGR %	21.2	12.43	1.39	9.41	2.64
Earnings From Cont. Operations, 5 Yr. CAGR %	22.79	15.76	3.41	9.74	5.29
Net Income, 5 Yr. CAGR %	22.79	15.76	3.41	9.74	5.29
Normalized Net Income, 5 Yr. CAGR %	21.47	13.92	3.4	10.58	5.31
Diluted EPS Before Extra, 5 Yr. CAGR %	22.79	15.76	3.41	9.74	5.29
Accounts Receivable, 5 Yr. CAGR %	21.89	12.06	13.13	14.08	13.15
Inventory, 5 Yr. CAGR %	16.47	17.31	12.43	11.67	13.01
Net Property, Plant and Equip., 5 Yr. CAGR %	19.08	18.5	16.44	11.8	14.39
Total Assets, 5 Yr. CAGR %	16.78	16.3	13.99	14.68	13.21
Tangible Book Value, 5 Yr. CAGR %	16.96	16.61	14.3	15.42	12.52
Common Equity, 5 Yr. CAGR %	16.96	16.6	14.3	15.41	12.52
Cash From Operations, 5 Yr. CAGR %	10.69	25.96	5.73	6.33	7.06
Capital Expenditures, 5 Yr. CAGR %	13.62	11.55	6.47	3.98	22.59
Levered Free Cash Flow, 5 Yr. CAGR %	-7.65	39.57	24.06	-7.24	4.11
Unlevered Free Cash Flow, 5 Yr. CAGR %	-7.66	39.54	22.7	-6.83	3.78
Dividend Per Share, 5 Yr. CAGR %	24.57	24.57	13.4	13.4	8.45